XML 20 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net income attributable to Myriad Genetics, Inc. stockholders $ 21.8 $ 125.3 $ 80.2
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 48.3 26.7 25.0
Non-cash interest expense 0.4    
Loss (gain) on disposition of assets (0.3) (0.9) 0.5
Share-based compensation expense 29.9 31.6 45.7
Impairment of cost basis investment 2.4    
Bad debt expense 37.3 33.3 31.5
Loss on extinguishment of debt 1.3    
Deferred income taxes 1.3 18.1 (0.4)
Unrecognized tax benefits 1.2 (2.4) 2.1
Change in fair value of contingent consideration (0.8)    
Excess tax benefit from share-based compensation     (3.4)
Changes in assets and liabilities:      
Prepaid expenses 7.8 (7.2) (5.5)
Trade accounts receivable (41.4) (39.2) (34.4)
Other receivables (4.0) (0.9) 2.5
Inventory (1.2) (14.6) (0.8)
Prepaid taxes 3.6 (3.8) 13.6
Accounts payable (3.0)   (3.1)
Accrued liabilities 0.7 0.5 (13.4)
Deferred revenue 0.9 (0.2) 0.4
Net cash provided by operating activities 106.2 166.3 140.5
CASH FLOWS FROM INVESTING ACTIVITIES      
Capital expenditures (6.1) (5.0) (23.9)
Acquisitions, net of cash acquired (216.1) (37.0) (20.1)
Sale of cost basis investment 2.6    
Purchases of marketable investment securities (87.5) (164.5) (80.7)
Proceeds from maturities and sales of marketable investment securities 160.8 115.1 165.6
Net cash provided by (used in) investing activities (146.3) (91.4) 40.9
CASH FLOWS FROM FINANCING ACTIVITIES:      
Net proceeds from common stock issued under share-based compensation plans 6.0 94.3 30.0
Net proceeds from revolving credit facility 204.0    
Net proceeds from term loan 199.0    
Repayment of term loan (200.0)    
Repayment of revolving credit facility (105.0)    
Fees paid for extinguishment of debt (0.6)    
Excess tax benefit from share-based compensation     3.4
Repurchase and retirement of common stock (31.6) (162.6) (210.7)
Net cash provided by (used in) financing activities 71.8 (68.3) (177.3)
Effect of foreign exchange rates on cash and cash equivalents 2.2 (2.2) (4.8)
Net (decrease) increase in cash and cash equivalents 33.9 4.4 (0.7)
Cash and cash equivalents at beginning of year 68.5 64.1 64.8
Cash and cash equivalents at end of year $ 102.4 $ 68.5 $ 64.1